|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Carcinoma of cervix accounts for 25-50% of total cancers and for 86-90% of all genital cancers in Indian women. Accurate staging of uterine cervical carcinoma is crucial in determining the mode of treatment. Clinical staging based primarily on pelvic examination, cystoscopy and proctoscopy is inaccurate and surgical staging for clinical stages II to IV generally is not routinely performed and has significant morbidity. For these reasons, CT and MR imaging may become a more accurate substitute for clinical staging of cervical carcinoma. The purpose of the study is to compare CT and MRI findings, in the evaluation and staging of uterine cervical carcinoma. Patients presenting to the departments of Oncology & gynecology, Chalmeda Anandrao Medical College Hospital and Cancer Hospital, Karimnagar with clinical suspicion of uterine cervical carcinoma were included in this study. The number of patients included in the study were twenty. In our study all the patients underwent both MR and CT imaging. Overall, the accuracy rates of CT and MR imaging for pelvic lymph node metastasis were equal in our study. The age of the patients ranged from 40 to 63 years with mean age being 48 years. The peak incidence was seen in the age group of 45 – 50 years. One of advantages of MR is in its ability to pick up lesions very early as compared to CT. Both MR and CT picked up all the lesions in our study .The accuracy of parametrial evaluation of CT was much less when compared to MR imaging. CT could not differentiate between the central tumor mass and the irradiated uterus. This was better seen on MR imaging which again has the ability to differentiate between fibrosis and recurrence. MR imaging should be used as routine for imaging study for preoperative staging of uterine cervical carcinoma.